A pharmacokinetic evaluation of five H1antagonists after an oral and intravenous microdose to human subjects-Reference-Cited by-同舟云学术

A pharmacokinetic evaluation of five H1antagonists after an oral and intravenous microdose to human subjects

Published:2009-03 Issue:3 Volume:67 Page:288-298
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Madan Ajay,O'Brien Zhihong,Wen Jianyun,O'Brien Chris,Farber Robert H.,Beaton Graham,Crowe Paul,Oosterhuis Berend,Garner R. Colin,Lappin Graham,Bozigian Haig P.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2008.03351.x/fullpdf

Reference21 articles.

1. Prevalence of insomnia in a survey of 12,778 adults in France;Leger;J Sleep Res,2000

2. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders;Mignot;Nat Neurosci,2002

3. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence;Meolie;J Clin Sleep Med,2005

4. Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay;Kubo;Jpn J Pharmacol,1987

5. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance;Kay;Arch Intern Med,1997

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a review;BMC Pulmonary Medicine;2024-08-29

2. The application of Phase 0 and microtracer approaches in early clinical development: past, present, and future;Frontiers in Pharmacology;2024-03-18

3. Strategic, feasibility, economic, and cultural aspects of phase 0 approaches;Clinical and Translational Science;2022-04-21

4. Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital;Journal of Pharmaceutical Health Care and Sciences;2021-08-02

5. Phase 0/microdosing approaches: time for mainstream application in drug development?;Nature Reviews Drug Discovery;2020-09-08